BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19808848)

  • 1. ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly.
    Sherlock M; Reulen RC; Alonso AA; Ayuk J; Clayton RN; Sheppard MC; Hawkins MM; Bates AS; Stewart PM
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4216-23. PubMed ID: 19808848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency.
    Petersons CJ; Mangelsdorf BL; Thompson CH; Burt MG
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2269-76. PubMed ID: 24606100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres.
    O'Reilly MW; Reulen RC; Gupta S; Thompson CA; Dineen R; Goulden EL; Bugg G; Pearce H; Toogood AA; Gittoes NJ; Mitchell R; Thompson CJ; Ayuk J
    Clin Endocrinol (Oxf); 2016 Nov; 85(5):748-756. PubMed ID: 27327840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in patients with pituitary disease.
    Sherlock M; Ayuk J; Tomlinson JW; Toogood AA; Aragon-Alonso A; Sheppard MC; Bates AS; Stewart PM
    Endocr Rev; 2010 Jun; 31(3):301-42. PubMed ID: 20086217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly.
    Ayuk J; Clayton RN; Holder G; Sheppard MC; Stewart PM; Bates AS
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1613-7. PubMed ID: 15070920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
    Agha A; Liew A; Finucane F; Baker L; O'Kelly P; Tormey W; Thompson CJ
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid replacement therapy and fibrinolysis in patients with hypopituitarism.
    Peacey SR; Wright D; Aye M; Moisey R
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):94-8. PubMed ID: 22151005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten years on: Safety of short synacthen tests in assessing adrenocorticotropin deficiency in clinical practice.
    Gleeson HK; Walker BR; Seckl JR; Padfield PL
    J Clin Endocrinol Metab; 2003 May; 88(5):2106-11. PubMed ID: 12727962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nationwide survey of mortality in acromegaly.
    Kauppinen-Mäkelin R; Sane T; Reunanen A; Välimäki MJ; Niskanen L; Markkanen H; Löyttyniemi E; Ebeling T; Jaatinen P; Laine H; Nuutila P; Salmela P; Salmi J; Stenman UH; Viikari J; Voutilainen E
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4081-6. PubMed ID: 15886256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypopituitarism.
    Higham CE; Johannsson G; Shalet SM
    Lancet; 2016 Nov; 388(10058):2403-2415. PubMed ID: 27041067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma.
    Zueger T; Kirchner P; Herren C; Fischli S; Zwahlen M; Christ E; Stettler C
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1938-42. PubMed ID: 22872686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients.
    Behan LA; Rogers B; Hannon MJ; O'Kelly P; Tormey W; Smith D; Thompson CJ; Agha A
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):505-13. PubMed ID: 21521342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy).
    Colao A; Vandeva S; Pivonello R; Grasso LF; Nachev E; Auriemma RS; Kalinov K; Zacharieva S
    Eur J Endocrinol; 2014 Aug; 171(2):263-73. PubMed ID: 24878680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study.
    Bogazzi F; Colao A; Rossi G; Lombardi M; Urbani C; Sardella C; Iannelli A; Scattina I; Manetti L; Del Sarto S; Pivonello R; Grasso LF; Lupi I; Auriemma RS; Lombardi G; Martino E
    Eur J Endocrinol; 2013 Sep; 169(3):367-76. PubMed ID: 23828855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved response of growth hormone to growth hormone-releasing hormone and reversible chronic thyroiditis after hydrocortisone replacement in isolated adrenocorticotropic hormone deficiency.
    Inagaki M; Sato H; Miyamoto Y; Hirukawa T; Sawaya A; Miyakogawa T; Tatsumi R; Kakuta T
    Tokai J Exp Clin Med; 2009 Jul; 34(2):34-8. PubMed ID: 21318995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mortality risk among women with acromegaly still persists.
    Găloiu S; Toma ID; Tănasie DI; Bărbulescu A; Baciu I; Niculescu DA; Trifănescu RA; Căpăţînă C; Radian Ş; Poiană C
    Front Endocrinol (Lausanne); 2024; 15():1348972. PubMed ID: 38449845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality.
    Burman P; Mattsson AF; Johannsson G; Höybye C; Holmer H; Dahlqvist P; Berinder K; Engström BE; Ekman B; Erfurth EM; Svensson J; Wahlberg J; Karlsson FA
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1466-75. PubMed ID: 23457412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess mortality in acromegaly.
    Holdaway IM
    Horm Res; 2007; 68 Suppl 5():166-72. PubMed ID: 18174739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure.
    Sherlock M; Behan LA; Hannon MJ; Alonso AA; Thompson CJ; Murray RD; Crabtree N; Hughes BA; Arlt W; Agha A; Toogood AA; Stewart PM
    Eur J Endocrinol; 2015 Nov; 173(5):583-93. PubMed ID: 26264718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis.
    Tritos NA; Johannsson G; Korbonits M; Miller KK; Feldt-Rasmussen U; Yuen KC; King D; Mattsson AF; Jonsson PJ; Koltowska-Haggstrom M; Klibanski A; Biller BM
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2018-29. PubMed ID: 24694339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.